NEW YORK, Nov 21 (Reuters) - An investigation into the marketing practices of Cephalon Inc. (CEPH.O: Quote, Profile, Research) found that the company illegally promoted its drugs -- including the powerful painkiller Actiq -- for uses for which they are not approved, according to the Connecticut Attorney General.
